1. Home
  2. ATAI vs CET Comparison

ATAI vs CET Comparison

Compare ATAI & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • CET
  • Stock Information
  • Founded
  • ATAI 2018
  • CET 1929
  • Country
  • ATAI Netherlands
  • CET United States
  • Employees
  • ATAI N/A
  • CET N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • CET Finance/Investors Services
  • Sector
  • ATAI Health Care
  • CET Finance
  • Exchange
  • ATAI Nasdaq
  • CET Nasdaq
  • Market Cap
  • ATAI 1.6B
  • CET 1.5B
  • IPO Year
  • ATAI 2021
  • CET N/A
  • Fundamental
  • Price
  • ATAI $3.66
  • CET $48.17
  • Analyst Decision
  • ATAI Strong Buy
  • CET
  • Analyst Count
  • ATAI 5
  • CET 0
  • Target Price
  • ATAI $14.00
  • CET N/A
  • AVG Volume (30 Days)
  • ATAI 5.2M
  • CET 55.4K
  • Earning Date
  • ATAI 11-12-2025
  • CET 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • CET 4.75%
  • EPS Growth
  • ATAI N/A
  • CET N/A
  • EPS
  • ATAI N/A
  • CET 7.40
  • Revenue
  • ATAI $3,018,000.00
  • CET $27,062,484.00
  • Revenue This Year
  • ATAI $736.04
  • CET N/A
  • Revenue Next Year
  • ATAI N/A
  • CET N/A
  • P/E Ratio
  • ATAI N/A
  • CET $6.54
  • Revenue Growth
  • ATAI 811.78
  • CET 15.78
  • 52 Week Low
  • ATAI $1.15
  • CET $40.24
  • 52 Week High
  • ATAI $6.75
  • CET $52.44
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 26.67
  • CET 26.45
  • Support Level
  • ATAI $3.72
  • CET $47.82
  • Resistance Level
  • ATAI $4.65
  • CET $49.03
  • Average True Range (ATR)
  • ATAI 0.35
  • CET 0.94
  • MACD
  • ATAI -0.13
  • CET -0.37
  • Stochastic Oscillator
  • ATAI 0.80
  • CET 6.06

About ATAI ATAI Life Sciences N.V.

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

About CET Central Securities Corporation

Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.

Share on Social Networks: